Consumer Adverse Drug Reactions (ADRs) Reporting in Malaysia: A Retrospective Analysis of Spontaneous Reports from the National Pharmacovigilance Database from 2008 to 2015

  • Vidhya Hariraj Department of Pharmacy, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
  • Zoriah Aziz Department of Pharmacy, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia

Abstract

Many countries are incorporating direct patient reporting of adverse drug reactions (ADRs) into their pharmacovigilance systems as patients provide a different insight into drug safety compared to healthcare professionals. In Malaysia, consumer reporting of ADRs and issues with product qualitiesbegan in 2007. The aim of this study was to examine consumer reports in terms of ADR categoriesby System Organ Class (SOC), suspected products and the seriousness of the ADRs.

Downloads

Download data is not yet available.

Author Biographies

Vidhya Hariraj, Department of Pharmacy, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia

Department of Pharmacy, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia

Zoriah Aziz, Department of Pharmacy, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia

Department of Pharmacy, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia

Statistics
23 Views | 27 Downloads
How to Cite
Hariraj, V., & Aziz, Z. (2017). Consumer Adverse Drug Reactions (ADRs) Reporting in Malaysia: A Retrospective Analysis of Spontaneous Reports from the National Pharmacovigilance Database from 2008 to 2015. Journal of Drug Delivery and Therapeutics, 7(7), 238. https://doi.org/10.22270/jddt.v7i7.1650